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In vitro and in vivo studies have shown that glutamate can be oxidized for energy by brain
astrocytes. The ability to harvest the energy from glutamate provides astrocytes with a
mechanism to offset the high ATP cost of the uptake of glutamate from the synaptic cleft.
This brief review focuses on oxidative metabolism of glutamate by astrocytes, the specific
pathways involved in the complete oxidation of glutamate and the energy provided by each
reaction.
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INTRODUCTION
One of the most essential roles of astrocytes in brain is removal of
the neurotransmitter glutamate from the synaptic cleft as it is cru-
cial that a low resting glutamate concentration of ∼1–10µM be
maintained for continued glutamatergic neurotransmission and
brain function (1–3). Astrocytes perform this key function by
rapidly and efficiently removing glutamate which increases orders
of magnitude in concentration to∼100µM–1 mM after depolar-
ization of neurons (4, 5). Uptake of glutamate is a very expensive
proposition since the astrocyte transporters that mediate gluta-
mate transport 3 Na+ molecules which must be exported by the
enzyme Na+, K+-ATPase. Thus the uptake of one molecule of
glutamate by an astrocyte requires the expenditure of one mole-
cule of ATP (1). To pay the high cost of removing large amounts
of glutamate from glutamatergic synapses, astrocytes must form
large amounts of ATP from the metabolism of glucose or other
substrates (see Figure 1A; Table 1). About 30% of the oxida-
tive metabolism in brain in vivo takes place in astrocytes (6–9);
however, it is not likely that these cells oxidize sufficient glucose
to generate the ATP required for the transport of such massive
amounts of glutamate (10–16). A number of groups have shown
that astrocytes have a sufficiently high rate of glutamate oxidative
metabolism to pay the high cost of glutamate uptake (11, 17, 18).
This short review summarizes the information on the use of glu-
tamate in astrocytes and recent evidence on the role of protein
complexes in facilitating glutamate metabolism (19, 20). The goal
of this paper is to provide a short, very concise, and focused review,
and to point readers to many excellent more in depth manuscripts
recently published (2, 3, 6, 16, 21).
WHAT IS THE EVIDENCE THAT GLUTAMATE IS METABOLIZED
BY ASTROCYTES?
It is well established that astrocytes can oxidize glucose and other
substrates for energy including lactate, glutamate, glutamine, fatty
acids, and the ketone bodies 3-hydroxybutyrate and acetoacetate
(12, 17, 22–30). These substrate are actively oxidized for energy;
however, glutamate is oxidized by astrocytes at a rate much higher
than the other substrates. The oxidation of glutamate by astro-
cytes was initially determined with studies using radiolabeled
14C-glutamate (12, 30–32). However, the more recent use of
13C-glutamate and 13C-NMR spectroscopy has provided more
complete information about the metabolic fate of glutamate in
astrocytes. Sonnewald et al. (18) first reported that more of the
label from glutamate metabolism was incorporated into lactate
by astrocytes than was converted to glutamine. This key finding
was initially considered controversial as it underscored that the
glutamate-glutamine cycle is not stoichiometric since only a por-
tion of the glutamate taken up by astrocytes was converted to glu-
tamine. A key study by the McKenna and Sonnewald (29) groups
demonstrated that when the exogenous glutamate concentration
was increased from 0.1 to 0.5 mM the proportion of glutamate
oxidized by the TCA cycle in astrocytes greatly increased and the
percent converted to glutamine decreased. Reports from many
groups clearly demonstrate (17, 29, 30, 33) that astrocytes have
the capability to oxidize the concentrations of glutamate present
in the synaptic cleft after depolarization of neurons (100µM–
1 mM) (4). Hertz and Hertz (17) noted that glutamate oxidation
by astrocytes is as high as the anaplerotic rate of glutamate pro-
duction suggesting that synthesis must be balanced by catabolism
as glutamate does not readily exit the brain. A recent report by our
group (11) showed that glutamate was oxidized by astrocytes at
a rate higher than glucose, 3-hydroxybutyrate, glutamine, lactate,
or malate, and that none of the other substrates could effectively
decrease the oxidative metabolism of glutamate.
Data from several different types of studies provide evidence
that suggests or demonstrates that glutamate oxidation occurs
in astrocytes in vivo. These include in vivo microdialysis studies
demonstrating oxidation of glutamate in the hippocampus of
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FIGURE 1A | Schematic diagram indicating the pathways of
metabolism of exogenous glutamate taken up by astrocytes. The
portion of the figure outlined with a dashed line shows transport of
glutamate from the extracellular milieu. The oval depicts the astrocytic
glutamate transporter GLT1/EAAT2 or GLAST; rectangle depicts Na+,
K+-ATPase. Astrocytic glutamate can be converted to α-ketoglutarate by
the energy producing enzyme glutamate dehydrogenase or via one of the
transaminase enzymes (primarily via aspartate aminotransferase but also
by BCAT and ALAT). α-Ketoglutarate formed from glutamate is metabolized
via a partial TCA cycle to either malate or oxaloacetate. For the complete
oxidation of glutamate to occur malate (or OAA) must leave the TCA cycle,
be converted to pyruvate by malic enzyme, and then converted to acetyl
CoA by pyruvate dehydrogenase. The acetyl CoA formed by these pyruvate
recycling reactions re-enters the TCA cycle and is subsequently oxidized
for energy. The dotted in the TCA cycle indicates that the NADH generated
from the isocitrate dehydrogenase reaction would only be formed when
the acetyl CoA formed from the pyruvate recycling pathway is metabolized
via the TCA cycle because the initial entry of carbons α-KG at is
subsequent to this step. The complete oxidation of one glutamate
molecule can yield 24–27 ATP depending on whether the initial step in
metabolism is via GDH or AAT. The ATP is estimated at ∼20 since the
maximum theoretical yield of ATP is never recovered due to mitochondrial
proton leak. [SeeTable 1 for reaction details and (B) for labeling pattern of
metabolites labeled from the initial metabolism of [U-13C]glutamate and
the labeling pattern from subsequent metabolism via the pyruvate
recycling pathway and re-entry into the TCA cycle]. Abbreviations: Glu,
glutamate; α-KG, α-ketoglutarate OAA, oxaloacetate; Asp, aspartate; GDH,
glutamate dehydrogenase; AAT aspartate aminotransferase; BCAT,
branched-chain aminotransferase; ALAT, alanine aminotransferase; KGDH,
α-ketoglutarate dehydrogenase; ME, malic enzyme; PDH, pyruvate
dehydrogenase; GS, glutamine synthetase. BCAA, branched chain amino
acid; BCKA, branched chain ketoacid.
freely moving rats (34, 35), evidence from several groups docu-
menting that the fine processes of astrocytes enveloping synaptic
terminals contain abundant mitochondria (6) (and Tibor Kristian,
unpublished), and transcriptome studies on astrocytes isolated
from brain of adult rodents that document very high levels of
transcripts for glutamate dehydrogenase (GDH) and for enzymes
of the TCA cycle (6).
OXIDATION OF THE CARBON SKELETON OF GLUTAMATE
OFFSETS THE COST OF GLUTAMATE UPTAKE
Glutamate taken up by astrocytes can be converted to α-
ketoglutarate by two reactions, either by transamination reactions
or by the energy producing reaction of the enzyme GDH which
is enriched in astrocytes (3, 6, 36, 37). Transamination occurs
primarily by aspartate aminotransferase (AAT), but also readily
takes place via either branched-chain amino acid aminotransferase
(BCAT) or alanine aminotransferase (ALAT) (3, 38–40). Stud-
ies from our group and others demonstrate that the oxidative
metabolism of exogenous glutamate taken up from the extracel-
lular milieu proceeds primarily via GDH in astrocytes from rat
brain [since it is relatively unaffected by the transaminase inhibitor
aminooxyacetic acid, AOAA] (30, 41). The α-ketoglutarate formed
from glutamate is metabolized for energy in the sequential reac-
tions of the TCA cycle to the four carbon compound oxaloacetate
(Figures 1A,B) and yielding the equivalent of nine ATP molecules
in this process.
THE COMPLETE OXIDATION OF GLUTAMATE REQUIRES
METABOLISM OF PART OF THE CARBON SKELETON VIA THE
PYRUVATE RECYCLING PATHWAY
Studies using 13C-NMR spectroscopy have provided key insights
into the metabolic fate of glutamate in astrocytes and information
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FIGURE 1B | Labeling pattern from the initial metabolism of
[U-13C]glutamate and the labeling pattern from the complete
oxidation of these glutamate carbons via the pyruvate recycling
pathway and re-entry into theTCA cycle. Labeling from the initial entry
of [U-13C]glutamate into the TCA cycle is shown inside the dotted line.
Note that metabolites generated are also uniformly labeled in all carbons.
[Note that any glutamine formed in the cytosol directly from
[U-13C]glutamate would also be uniformly labeled [U-13C]glutamine;
reaction not shown in this figure]. [U-13C]malate or OAA leaving the TCA
cycle would be converted to [U-13C]pyruvate by malic enzyme or the
combined action of PEPCK and pyruvate kinase, and would also give rise
to [U-13C]lactate. The [U-13C]pyruvate can be converted to [1,2-13C]acetyl
CoA which enters the TCA cycle for further oxidation. Any citrate formed
from the condensation of the [1,2-13C]acetyl CoA with unlabeled
oxaloacetate in the cycle would give rise to [4,5-13C]glutamate and
glutamine, and also to both [1,2-13C]aspartate and [3,4-13C]aspartate. These
partially labeled glutamate, glutamine, and aspartate molecules can be
readily distinguished from the [U-13C]glutamate, glutamine, and aspartate
by 13C-NMR spectroscopy. It is very likely that studies of pyruvate recycling
from [U-13C]glutamate underestimate the amount of recycling taking place
since any citrate formed from the condensation of [1,2-13C]acetyl CoA with
[U-13C]OAA formed from the initial entry and metabolism of the glutamate
into the TCA cycle give rise to [U-13C]glutamate which can not be
distinguished from the precursor. Abbreviations: Glu, glutamate; Gln,
glutamine; OAA, oxaloacetate; Asp, aspartate; Lac, lactate; Pyr, pyruvate;
ME, malic enzyme; PEPCK, phosphoenolpyruvate carboxykinase.
about the compartmentation of glutamate metabolism (28, 29,
42–44). Several groups have shown that the carbon skeleton of
glutamate can enter the TCA cycle leading to labeling in aspartate
and lactate (28, 29, 42–44). The incorporation of label from
[U-13C]glutamate into [U-13C]lactate (see Figure 1B) and also
into [1,2-13C]glutamate and glutamine and specifically labeled
molecules of aspartate confirms that the carbon skeleton of glu-
tamate can be metabolized via the pyruvate recycling pathway
in astrocytes and reenter the TCA cycle. Thus, all carbons of
the glutamate molecule can be completely oxidized for energy
via the TCA cycle and pyruvate recycling pathway (45) (see
Figure 1B).
OTHER SUBSTRATES CAN FACILITATE THE UPTAKE AND
OXIDATIVE METABOLISM OF GLUTAMATE BY ASTROCYTES
The high rate of glutamate oxidation reported by several groups is
consistent with the earlier findings of Hertz and Hertz (17) demon-
strating that 100µM glutamate supported O2 uptake by astrocytes
as effectively as 7.5 mM glucose. Hertz also demonstrated that O2
uptake and respiration was significantly higher with the combi-
nation of glutamate+ glucose than with either substrate alone
(17). Data from several studies suggests that glucose may facilitate
the uptake and oxidation of glutamate by astrocytes. McKenna
et al. (30) showed that the presence of 1 mM pyruvate increased
the rate glutamate oxidation by astrocytes, possibly by increas-
ing transamination to α-ketoglutarate and metabolism via the
TCA cycle in the presence of pyruvate. However, we did not
find any effect of glucose or lactate on rate of 14CO2 produc-
tion from [U-14C]glutamate in a recent study (11). In contrast,
studies by some groups showed that glutamate uptake stimulated
glycolysis in astrocytes; however, this has not been found by all
groups (46, 47).
OXIDATION OF GLUTAMATE FOR ENERGY SPARES GLUCOSE
AND OTHER SUBSTRATES
Substrate competition studies recently reported by our group
demonstrated the robustness of glutamate use by astrocytes as
none of the other substrates added, including glucose, had the
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Table 1 | Energy produced in astrocytes from oxidation of one glutamate molecule in theTCA cycle and oxidation via the pyruvate recycling
pathway.
Energy required for uptake of one molecule of glutamate
Uptake by EAAT2 (GLT1) or GLAST Rebalancing ions ATP used
1 Glutamate+3 Na++2 K++1 H+ taken up → 3 Na+ extruded 1
Energy provided by complete oxidation of one molecule of glutamate
Reaction ATP equivalents
(theoretical maximum)
GDH (glutamate dehydrogenase) reaction
Glutamate→ α-ketoglutarate NADPH 3
ATP equivalents from one Glu metabolized via GDH rxn 3
or ATP equivalents from AAT rxn 0
TCA cycle reactions
α-Ketoglutarate→ succinyl CoA NADH 3
Succinyl CoA→ succinate GTP 1
Succinate→ fumarate FADH2 2
Fumarate→malate 0
ATP equivalents produced from one Glu metabolized via partialTCA cycle to malate 6
Malate can stay in theTCA cycle or be metabolized via pyruvate recycling pathway:
(calculations below assume that carbons from one Glu is metabolized via pyruvate recycling)
Carbons from one Glu staying in TCA cycle (rather than pyruvate recycling)
Malate→oxaloacetate NADH 3**
Carbons from one Glu metabolized via the pyruvate recycling pathway
Pyruvate recycling pathway
Malate→pyruvate NADPH 3
Pyruvate→ acetyl CoA NADH 3
From acetyl moiety derived from one glutamate re-entering TCA cycle
Acetyl CoA→oxaloacetate (one complete turn of TCA cycle) 3 NADH 9
1 FADH2 2
1 GTP 1
ATP equivalents from pyruvate recycling and oxidation of acetyl moiety 18**
Total ATP from complete oxidation of one molecule of exogenous glutamate
via theTCA cycle and pyruvate recycling pathway 24–27*
NET energy yield from uptake and oxidation of one glutamate molecules 23–26***
*Values with asterisks includes the ATP generated from the reoxidation of NADPH formed during conversion of glutamate to α-ketoglutarate in the reaction catalyzed
by glutamate dehydrogenase (GDH).
**Note that when the carbon skeleton from metabolism of glutamate leaves theTCA cycle as malate to proceed through the pyruvate recycling pathway, then NADH
will not be formed by malate dehydrogenase (MDH) which converts malate→OAA. However, with multiple molecules of glutamate entering oxidative metabolic
pathways in astrocytes some of the glutamate would be converted to OAA and be used for formation of citrate and producing NADH at the MDH step. Note that if a
glutamate molecule stays in the TCA cycle 9–12 molecules of ATP would be produced which is less than when it is metabolized via the pyruvate recycling pathway
but still considerably more than the ATP required for glutamate transport.
***The total ATP generated would be 27 if glutamate→ α-ketoglutarate proceeds via the GDH reaction, and only 24 if it proceeds via AAT. The ATP values are
estimates as noted in Figure 1A since the maximum theoretical yield of ATP is never recovered due to the mitochondrial proton leak.
ability to decrease the oxidation of glutamate (11). Hertz and Hertz
(17) found higher respiration and O2 consumption when astro-
cytes were incubated in the presence of glutamate plus glucose
and that the addition of glutamate spared glucose consumption.
Earlier studies by Peng et al. (48) showed that added glutamate
decreased the rate of glucose oxidation in astrocytes by 75%.
ASTROCYTE GLUTAMATE TRANSPORTERS AND
MITOCHONDRIAL PROTEINS FORM COMPLEXES THAT
FACILITATE OXIDATION OF GLUTAMATE FOR ENERGY IN
ASTROCYTES
Recent reports from the Robinson lab (19, 20) demonstrate that
glutamate uptake by astrocytes is tightly associated with a multi
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protein complex which includes the glial glutamate transporters,
hexokinase and mitochondrial proteins suggesting that there is
a mechanism in astrocytes that insures that a portion of the
glutamate taken up is selectively delivered to mitochondria for
oxidative energy metabolism. They demonstrated that the astro-
cyte glutamate transporter GLT1 can co-compartmentalize with
hexokinase, other glycolytic enzymes, GDH, and mitochondria
(20, 49). A report from the Robinson group in this special issue
(49) suggesting that the enzyme GDH associates with the astrocyte
glutamate transporters strengthens the evidence for the formation
of a protein complex to facilitate the mitochondrial oxidation of
glutamate.
Overall, there is compelling data from both in vitro and in vivo
studies that oxidative metabolism of glutamate occurs in astro-
cytes and provides sufficient energy to pay for the cost of glutamate
uptake from the synaptic cleft.
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